0001415889-21-003266.txt : 20210629 0001415889-21-003266.hdr.sgml : 20210629 20210629191311 ACCESSION NUMBER: 0001415889-21-003266 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210625 FILED AS OF DATE: 20210629 DATE AS OF CHANGE: 20210629 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Sheena Jonathan CENTRAL INDEX KEY: 0001646649 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37478 FILM NUMBER: 211059698 MAIL ADDRESS: STREET 1: C/O NATERA, INC. STREET 2: 201 INDUSTRIAL ROAD, SUITE 410 CITY: SAN CARLOS STATE: CA ZIP: 94070 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Natera, Inc. CENTRAL INDEX KEY: 0001604821 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071] IRS NUMBER: 010894487 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 13011 MCCALLEN PASS STREET 2: BUILDING A SUITE 100 CITY: AUSTIN STATE: TX ZIP: 78753 BUSINESS PHONE: 650-249-9090 MAIL ADDRESS: STREET 1: 13011 MCCALLEN PASS STREET 2: BUILDING A SUITE 100 CITY: AUSTIN STATE: TX ZIP: 78753 4 1 form4-06292021_040654.xml X0306 4 2021-06-25 0001604821 Natera, Inc. NTRA 0001646649 Sheena Jonathan C/O NATERA, INC. 13011 MCCALLEN PASS BUILDING A SUITE 100 AUSTIN TX 78753 true false false true CO-FOUNDER Common Stock 2021-06-25 4 M 0 87 5.3953 A 455472 D Common Stock 2021-06-25 4 S 0 87 121.6314 D 455385 D Common Stock 2021-06-25 4 M 0 52 9.59 A 455437 D Common Stock 2021-06-25 4 S 0 52 121.6285 D 455385 D Common Stock 2021-06-25 4 M 0 700 10.41 A 456085 D Common Stock 2021-06-25 4 S 0 700 121.5829 D 455385 D Common Stock 2021-06-25 4 M 0 700 9.29 A 456085 D Common Stock 2021-06-25 4 S 0 700 121.5871 D 455385 D Common Stock 2021-06-27 4 M 0 446 A 455831 D Common Stock 2021-06-28 4 S 0 201 117.5714 D 455630 D Stock Option (right to buy) 5.3953 2021-06-25 4 M 0 87 0 D 2026-04-07 Common Stock 87 1958 D Stock Option (right to buy) 9.59 2021-06-25 4 M 0 52 0 D 2026-04-07 Common Stock 52 40778 D Stock Option (right to buy) 10.41 2021-06-25 4 M 0 700 0 D 2027-06-08 Common Stock 700 38368 D Stock Option (right to buy) 9.29 2021-06-25 4 M 0 700 0 D 2028-03-08 Common Stock 700 21453 D Restricted Stock Unit 2021-06-27 4 M 0 446 0 D Common Stock 446 4917 D The sales reported in the Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 1, 2021. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $121.02 to $121.55 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $121.04 to $121.55 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $121.10 to $121.53 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $121.11 to $121.53 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Represents the partial vesting and settlement of Restricted Stock Units ("RSUs"), starting March 27, 2021. Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. The sale of shares was effected in order to satisfy tax withholding and remittance obligations in connection with the vesting of RSUs in compliance with Rule 10b5-1. The option shares vested fully and became exercisable on November 20, 2019. The option shares vested fully and became exercisable on April 1, 2020. The option shares vested fully and became exercisable on March 21, 2021. The option shares vest over four years. 25% of the option shares vested and became exercisable on March 9, 2019 and the remaining shares vest in 36 equal monthly installments thereafter. The RSUs vest over four years. 25% of the RSUs vested on March 27, 2021 and the remaining shares vest in 12 equal quarterly installments thereafter. /s/ Tami Chen, Attorney-in-Fact 2021-06-29